| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/29/2002 | US6342501 Viricides |
| 01/29/2002 | US6342497 2″-deoxy hygromycin derivatives |
| 01/29/2002 | US6342494 Carbapenem compounds, use thereof, and intermediate compounds of the same |
| 01/29/2002 | US6342493 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 01/29/2002 | US6342492 Anti-viral triaza compounds and compositions |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342234 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 01/29/2002 | US6342233 Pseudomonas treatment composition and method |
| 01/29/2002 | US6342232 For prophylaxis of otitis media |
| 01/29/2002 | US6342231 Haemophilus parasuis vaccine and diagnostic |
| 01/29/2002 | US6342230 Materials and methods for prevention or reduction of the severity of heartwater |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342223 Conjugate vaccine capable of conferring host immunity to an infection by group b streptococcus which comprises polysaccharide conjugated to protein |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2092330C Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof |
| 01/29/2002 | CA2079328C Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof |
| 01/24/2002 | WO2002006821A2 Antimicrobial agent |
| 01/24/2002 | WO2002006513A2 A method for treating herpes viruses |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006347A1 A selectively-expressed epitope on the human cd38 molecule detected by a phage display library-derived human scfv antibody fragment |
| 01/24/2002 | WO2002006324A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | WO2002006316A2 Alpha-msh related compounds and methods of use |
| 01/24/2002 | WO2002006303A2 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | WO2002006289A1 Process for the preparation of highly pure crystalline (r,s) - cefuroxime axetil |
| 01/24/2002 | WO2002006288A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 01/24/2002 | WO2002006284A1 Indoloquinazolinones |
| 01/24/2002 | WO2002006283A1 Improved preparation of (4r, 5s, 6s)-3-(((2r,3r)-2-((((s)-2-amino-3-methyl-1-oxobutyl)methyl)tetrahydro-3-furanyl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid |
| 01/24/2002 | WO2002006278A1 Oxazolidinone derivatives as antimicrobials |
| 01/24/2002 | WO2002006271A1 Pyrimidine derivatives |
| 01/24/2002 | WO2002006270A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | WO2002006259A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv) |
| 01/24/2002 | WO2002006249A1 Method for producing 1-substituted-1,2,3-triazole derivative |
| 01/24/2002 | WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | WO2002006224A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 01/24/2002 | WO2002006222A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/24/2002 | WO2002006190A2 Crystalline and salt forms of an hiv protease inhibitor |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005850A2 Enhancement of the action of anti-infective agents |
| 01/24/2002 | WO2002005846A1 Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen, and preparation method thereof |
| 01/24/2002 | WO2002005845A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| 01/24/2002 | WO2002005839A1 Agent for inhibiting adhesion of the pathogenic flora of the skin |
| 01/24/2002 | WO2002005838A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | WO2002005828A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | WO2002005814A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2002005802A1 Method of fundamentally treating common cold |
| 01/24/2002 | WO2002005801A2 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | WO2002005796A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | WO2002005786A1 Pharmaceutical composition improved in peroral absorbability |
| 01/24/2002 | WO2002005784A1 A medicinal aerosol formulation |
| 01/24/2002 | WO2001066132A3 Hiv immune adjuvant therapy |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001041785A3 Enzyme treatment for infection |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001038305A3 Novel il-8 receptor antagonists |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001032154A3 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 01/24/2002 | WO2001029037A3 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | WO2001010454A3 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | WO2000069428A3 Anionic polymers as toxin binders and antibacterial agents |
| 01/24/2002 | WO2000056303A3 Treatment of immune diseases |
| 01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
| 01/24/2002 | US20020010550 Pharmacokinetic-based drug design tool and method |
| 01/24/2002 | US20020010322 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments |
| 01/24/2002 | US20020010317 Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins |
| 01/24/2002 | US20020010316 Thiazole derivatives |
| 01/24/2002 | US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure. |
| 01/24/2002 | US20020010193 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
| 01/24/2002 | US20020010190 N-heterocyclic derivatives as NOS inhibitors |
| 01/24/2002 | US20020010170 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009740 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 01/24/2002 | US20020009491 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/24/2002 | US20020009490 Aids; administering mixture containing germanium sesquioxide and interferon |
| 01/24/2002 | US20020009483 Topical administration of oxazolidinones for transdermal delivery |
| 01/24/2002 | US20020009463 Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009447 Vaccinia virus infections |
| 01/24/2002 | US20020009436 Using enzymes |
| 01/24/2002 | US20020009433 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 01/24/2002 | US20020009429 Pharmaceutical composition comprising a selected antigen and candida species antigen and methods |
| 01/24/2002 | DE10034137A1 Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat und einem oder mehreren 4-Hydroxybenzoesäureestern und Zubereitungen, solche Wirkstoffkombinationen enthaltend Active compound combinations of 3-iodo-2-propynyl butyl carbamate and one or more 4-hydroxybenzoic acid and preparations such active ingredient combinations |
| 01/24/2002 | DE10034136A1 Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat, einem oder mehreren 4-Hydroxybenzoesäureester und Phenoxyethanol und Zubereitungen, solche Wirkstoffkomibnationen enthaltend Active compound combinations of 3-iodo-2-propynyl butyl carbamate, one or more 4-hydroxybenzoic acid esters and phenoxyethanol and preparations containing such Wirkstoffkomibnationen |